APHIS HomeAbout APHISNewsroomCareer OpportunitiesHelpContact Us
Decrease Font Size Increase Font Size
USDA in Facebook APHIS in Twitter APHIS in Youtube APHIS Stakeholder Registry APHIS in Pictures APHIS in Blog APHIS RSS News Feeds

Browse by Subject
Animal Health
Animal Welfare
Emergency Preparedness and Response
Import and Export
International Services
Plant Health
Regulations and Assessments
APHIS User Fees
Wildlife Control and Management

Printable version

Suzan Holl (301) 734-6464
Jerry Redding (202) 720-6959


WASHINGTON, Jan. 31, 2006–The U.S. Department of Agriculture today announced that it has issued a license to Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, for a vaccine to protect chickens from illness caused by the Newcastle disease virus (NDV).

The chicken vaccine is the first fully licensed plant-cell-produced vaccine for animals in the United States and the first plant-made product to be licensed by USDA’s Animal and Plant Health Inspection Service. The vaccine contains the major immunogenic protein of the NDV and does not contain any whole NDV, live or killed. Once the chicken’s cells take up the protein in the vaccine, they trigger a protective immune response.

In granting full licensure, APHIS’ Center for Veterinary Biologics determined that the vaccine’s safety and efficacy have been satisfactorily demonstrated. The label conforms to standard precautions regarding use.

NDV occurs in many species of birds, is transmitted by inhalation and ingestion and displays wide variation in pathogenicity among strains. NDV strains are classified as asymptomatic, lentogenic (mildly pathogenic), mesogenic (moderately pathogenic) and velogenic (highly pathogenic).

NDV can be either neurotropic or viscerotropic. The neurotropic viruses cause respiratory and nervous signs. The viscerotropic viruses, which are more common, result in respiratory signs, diarrhea and swelling of the head and neck. Vaccination is the principle method of control for the mildly pathogenic strains common to the United States.

Plant-cell-produced technology represents a new generation of vaccines. First, plant-cell-produced vaccines contain no components of animal origin. Second, traditional vaccine development involves either passing a disease-producing virus through a different species or cell type until it no longer causes disease but does create immunity, or by killing the virus in a way that allows it to produce immunity but no disease in the recipient. Plant-cell-produced subunit vaccines use only specific fragments of a pathogen’s unique genetic material to stimulate a targeted immune response from the host.


Note to Reporters: USDA news releases, program announcements and media advisories are available on the Internet. Go to the APHIS new release page at http://www.aphis.usda.gov/lpa/newsroom/. Also, anyone with an e-mail address can sign up to receive APHIS press releases automatically. Send an e-mail message to lyris@mdrdlyriss10.aphis.usda.gov and leave the subject blank. In the message, type subscribe press_releases.



[an error occurred while processing this directive]